ILMN vs TECH · rev $4.34B vs P/E 65, rev $1.22B
Illumina Inc (ILMN) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Illumina Inc (ILMN) is a diagnostics & research company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported ILMN revenue for 2025-12-28 was $4.34B. Net income was $850.0M. Revenue was down 0.7% from 2024-12-29 to 2025-12-28. ILMN currently screens at market cap $15.84B.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
ILMN currently screens at market cap $15.84B. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the ILMN and TECH stock pages for the full models.
Not investment advice.